Prognosis of second primary oral squamous cell carcinoma after hematologic malignancy: a retrospective cohort analysis
Frontiers in Oncology · 03.09.2025 · 15
DOI: 10.3389/fonc.2025.1667226 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Oncology, online erschienen am 03.09.2025. Verfasst von Huajiao Yu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oral and Maxillofacial-Head and Neck Oncology, Beijing Stomatological Hospital, Capital Medical University, Beijing, China. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Backgrounds Prognosis and optimal management strategies of second primary oral squamous cell carcinoma (OSCC) following a history of hematologic malignancies (HM) remain uncertain. We investigated whether HM history affects OSCC outcomes or necessitates treatment modifications. Patients and methods This retrospective cohort study included 2486 OSCC patients: 14 with OSCC as a second primary malignancy post-HM (SPM group) and 2472 with primary OSCC (non-SPM group). Using propensity score matching (PSM), we created two cohorts: 1:17 (13 SPM vs 232 non-SPM) and 1:3 (13 SPM vs 38 non-SPM). Outcomes were disease-free survival (DFS), overall survival (OS), and disease-specific survival (DSS). Survival differences were analyzed using log-rank tests. Multivariate Cox regression identified prognostic predictors.
Results
No significant survival differences existed between SPM and non-SPM groups in either cohort (1:17: DFS 53.8% vs 68.9%, p=0.102; OS 69.2% vs 81.3%, p=0.170; DSS 69.2% vs 82.2%, p=0.147. 1:3: DFS 53.8% vs 63.2%, p=0.302; OS 69.2% vs 76.3%, p=0.532; DSS 69.2% vs 78.9%, p=0.430). Cox regression identified independent predictors: DFS: Age (p=0.001), T stage (p<0.001), N stage (p<0.001); OS and DSS: Age (p<0.001), T stage (p<0.001), N stage (p<0.001), pathological grade (p<0.001), prior HM was not an independent predictor.
Conclusions
A history of HM does not independently predict the prognosis of second primary OSCC nor necessitate modifications to standard OSCC treatment.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Oral and Maxillofacial-Head and Neck Oncology, Beijing Stomatological Hospital, Capital Medical University, Beijing, China.
- Department of Oral and Maxillofacial Surgery, Affiliated Hospital of Inner Mongolia Medical University, Hohhot, Inner Mongolia, China.
Zitieren
APA
Yu, H., Li, B., Huang, Y., Zhang, X., Zhou, H., Feng, Z., & Han, Z. (2025). Prognosis of second primary oral squamous cell carcinoma after hematologic malignancy: a retrospective cohort analysis. Frontiers in Oncology, 15. https://doi.org/10.3389/fonc.2025.1667226
Vancouver
Yu H, Li B, Huang Y, Zhang X, Zhou H, Feng Z, et al. Prognosis of second primary oral squamous cell carcinoma after hematologic malignancy: a retrospective cohort analysis. Frontiers in Oncology. 2025;15. doi:10.3389/fonc.2025.1667226
BibTeX
@article{Yu2025,
author = {Yu, Huajiao and Li, Bo and Huang, Yu and Zhang, Xue and Zhou, Hanchen and Feng, Zhien and Han, Zhengxue},
title = {Prognosis of second primary oral squamous cell carcinoma after hematologic malignancy: a retrospective cohort analysis},
journal = {Frontiers in Oncology},
year = {2025},
volume = {15},
doi = {10.3389/fonc.2025.1667226}
}
EUVIMED